MARKET

LPCN

LPCN

Lipocine Inc
NASDAQ
2.260
+0.040
+1.80%
After Hours: 2.260 0 0.00% 16:53 05/22 EDT
OPEN
2.220
PREV CLOSE
2.220
HIGH
2.266
LOW
2.217
VOLUME
61.27K
TURNOVER
--
52 WEEK HIGH
12.37
52 WEEK LOW
1.810
MARKET CAP
18.63M
P/E (TTM)
-1.1540
1D
5D
1M
3M
1Y
5Y
1D
Lipocine Showcases Phase 3 Data for Postpartum Depression
TipRanks · 4d ago
Lipocine Phase 3 postpartum depression trial data for LPCN 1154 set for ASCP talk
PUBT · 4d ago
Lipocine To Announce Phase 3 Data For LPCN 1154 Treatment For Postpartum Depression On May 26
Benzinga · 4d ago
LIPOCINE ANNOUNCES LPCN 1154 PHASE 3 DATA ACCEPTED FOR ORAL PRESENTATION AT 2026 ASCP ANNUAL MEETING
Reuters · 4d ago
Lipocine Showcases Pipeline at Virtual Healthcare Conference
TipRanks · 5d ago
Lipocine joins A.G.P. Annual Healthcare Company Showcase fireside chat
PUBT · 5d ago
Weekly Report: what happened at LPCN last week (0511-0515)?
Weekly Report · 5d ago
Weekly Report: what happened at LPCN last week (0504-0508)?
Weekly Report · 05/11 10:02
More
About LPCN
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics. The Company’s clinical development candidates include: LPCN 1154, oral brexanolone, for the treatment of postpartum depression, LPCN 2101, for the treatment of epilepsy, LPCN 2203, an oral candidate targeted for the management of essential tremor, LPCN 2401, an oral proprietary anabolic androgen receptor agonist for improved body composition in obesity management, and LPCN 1148, for the management of decompensated cirrhosis. It is also developing LPCN 1107, for the prevention of preterm birth, LPCN 1154, for rapid relief of postpartum depression, and LPCN 1144, for the treatment of metabolic dysfunction-associated steatohepatitis. Its product candidate, TLANDO, is a novel oral prodrug of testosterone containing testosterone undecanoate developed by the Company.

Webull offers Lipocine Inc stock information, including NASDAQ: LPCN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LPCN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LPCN stock methods without spending real money on the virtual paper trading platform.